WebOur Company — DiscGenics. About Us. DiscGenics is a privately held, clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that ... Our Mission. Our Values. … WebDec 14, 2024 · DiscGenics has 40 employees, and the revenue per employee ratio is $47,500. DiscGenics peak revenue was $1.9M in 2024. Peak Revenue $1.9M (2024) Number of Employees 40 Revenue / Employee $47,500 Peak Revenue $1.9M (2024) Number of Employees 40 Revenue / Employee $47,500 DiscGenics Jobs Location …
Careers — DiscGenics
WebJan 4, 2024 · DiscGenics Completes Patient Enrollment in Japanese Clinical Study of Cell Therapy for Disc Degeneration as US Study Achieves One-Year Follow-up Milestone. DiscGenics has enrolled a total of 38 subjects in its Japanese clinical study of IDCT. Meanwhile in the U.S., all currently enrolled trial subjects have completed their one-year … WebAs DiscGenics mission is to improve the lives of millions of people worldwide, DiscGenics employees take this mission to heart and look for philanthropic opportunities in their local … mart uniontown pa
Investors & Media — DiscGenics
WebCareers 会社案内 ... At DiscGenics, we are focused on developing regenerative therapies that alleviate pain and restore function in patients with degenerative diseases of the spine. As major contributors to low back pain, degenerative diseases of the spine pose a major public health concern that can lead to missed work, lost wages and ... WebDiscGenics uses its patented allogeneic cell culture manufacturing technology to isolate cells from donated adult human intervertebral disc tissue and induce a progenitor state. These proprietary Discogenic Cells are then expanded for therapeutic application, combined with a delivery vehicle and cryopreserved for off-the-shelf use. WebGrow your career in cell therapy with DiscGenics. LEARN MORE . Featured News. News Posts. Feb 28, 2024. DiscGenics to Present at Canaccord Genuity’s 2024 … marturano recreation company